UV CINNEMARK GOLD 4 X ET 32690#SR-04026 #T145-1-1 Purple X ET 32690#SR-04023 #T085-1-1 Red

X PP-15424-02-2 RACER RED 3 TEST FORMULA #4

PCR PALE BLUE Q290-7-4 OKA-B CAMEL 3 X 15095-03-7

Microsoft PowerPoint - AVNT Q3 2024 Earnings Presentation_10.29_12PM AVIENT CORPORATION T H I R D Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) O C T O B E R 3 1 , 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. EBITDA $130 million +6% (+7% ex FX)Net Sales $815 million +8% (+8.5% ex FX) Net Sales $815 million +8% (+8.5% ex FX) Q 3 2 0 2 4 R E S U L T S TOTAL COMPANY ( Q 3 2 0 2 4 P E R F O R M A N C E V S Q 3 2 0 2 3 ) $754 $815 Q3 23 Q3 24 $123 $130 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) $0.57 $0.65 Q3 23 Q3 24 (in millions) Adjusted EBITDA Adjusted EPS 5 + 8% (+8.5% excluding FX) + 6% (+7% excluding FX) + 14% (+16% excluding FX) Sales 6 Q3 2 024 RESULTS – ORGA NI C REVENUE GROW TH BY REGI ON VS PY 6 US & Canada Latin America EMEA Asia +9% +5% +11% +27% Avient ex. FX +8.5% FX -0.4% Total Avient +8.1% Note: Regional Sales Percentages exclude impact of foreign exchange COLOR, ADDITIVES & INKS SEGMENT ( Q 3 2 0 2 4 P E R F O R M A N C E V S Q 3 2 0 2 3 ) $487 $522 Q3 23 Q3 24 $89 $97 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 7 + 7% (+8% excluding FX) + 9% (+11% excluding FX) 18.3% +40 bps *18.7% * * Adjusted EBITDA Margin % • Sales growth driven by winning new product specifications in consumer & packaging, strong underlying demand in healthcare and improving demand in building & construction • Favorable mix and raw material deflation contributed to EBITDA margin expansion SPECIALTY ENGINEERED MATERIALS SEGMENT ( Q 3 2 0 2 4 P E R F O R M A N C E V S Q 3 2 0 2 3 ) $268 $295 Q3 23 Q3 24 $51 $57 Q3 23 Q3 24 Sales Adjusted EBITDA (in millions) (in millions) Sales Adjusted EBITDA 8 • Sales growth driven by restocking in healthcare & consumer end markets and strong underlying demand for composite applications used in building & construction, energy and defense end markets • Favorable mix contributed to EBITDA margin expansion + 10% (+10% excluding FX) + 12% (+13% excluding FX) 19.0% +40 bps *19.4% * * Adjusted EBITDA Margin % 2 0 2 4 G U I D A N C E FY 20 24 GUIDA NC E Previous (Aug 6) Current Adjusted EPS $2.55 to $2.70 $2.63 to $2.67 Adjusted EBITDA $515 to $540 million $525 to $530 million Interest Expense $105 million $104 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures & Investment in S/4 Hana ~$140 million ~$140 million 10 11 • Investor Day to be held December 4, 2024 at the NYSE, beginning at 10AM • The focus will be to do a deep dive on the Company’s strategy • Registration and microsite will be available in early November 20 24 AVI ENT INVESTOR DAY A P P E N D I X 18 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RA W MATERI AL BA SKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 20 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 21 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR , AD DI TI VES & INKS 2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N US & Canada 52% EMEA 35% Asia 13% 22 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPEC IA LTY ENGI NEER ED MATERI ALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 3 AV I E N T R E G I O N A L S A L E S Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 23 B Y E N D M A R K E T Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

KR01 BLUE TINT #4 RED BROWN 4 X PDS 16282-01-1 Translucent White

X LB-66579-404-1B PERIWINKLE 3 BLUE # 4 T-225-3-3

EBITDA $143 million +9% Net Sales $850 million +3% (+5% ex FX) Net Sales $850 million +3% (+5% ex FX) Adj. EBITDA Margin 16.9% +100 bps Q 2 2 0 2 4 R E S U L T S Q2 2024 PERFORMANCE VS. Q2 2023 ( T O TA L C O M PA N Y ) $824 $850 Q2 23 Q2 24 $131 $143 Q2 23 Q2 24 Sales Adjusted EBITDA (in millions) $0.63 $0.76 Q2 23 Q2 24 (in millions) Adjusted EBITDA Adjusted EPS 5 + 3% (+5% excluding FX) + 9% (+12% excluding FX) + 21% (+25% excluding FX) Sales 6 Q2 2 024 RESULTS – ORGA NI C SA LES BY REGION VS PY 6 US & Canada Latin America EMEA Asia +5% +4% +1% +19% Avient ex.

X GV 40834#SR-02514-0003-10 Pink N NEUTRAL 4 GRAY Q710-1-4 PC

TRANS GRAY T705-1-3 X ST465-001-02 DEL BLUE Q310-4-1

EBITDA $143 million +9% Net Sales $850 million +3% (+5% ex FX) Net Sales $850 million +3% (+5% ex FX) Adj. EBITDA Margin 16.9% +100 bps Q 2 2 0 2 4 R E S U L T S Q2 2024 PERFORMANCE VS. Q2 2023 ( T O TA L C O M PA N Y ) $824 $850 Q2 23 Q2 24 $131 $143 Q2 23 Q2 24 Sales Adjusted EBITDA (in millions) $0.63 $0.76 Q2 23 Q2 24 (in millions) Adjusted EBITDA Adjusted EPS 8 + 3% (+5% excluding FX) + 9% (+12% excluding FX) + 21% (+25% excluding FX) Sales 9 Q2 2 024 RESULTS – ORGA NI C SA LES BY REGION VS PY 9 US & Canada Latin America EMEA Asia +5% +4% +1% +19% Avient ex.